BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility's expansion, designed to conform to GMP standard, is now almost complete and is expected to start manufacturing cGMP grade cells in April this...

March 15, 2022 | News

SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark f...

February 25, 2022 | News

First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution

Hiroshima University is home to one of the largest university research institutes in the field of radiation biomedical science in Japan. With NGS...

February 23, 2022 | News

National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development

The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...

February 07, 2022 | News

Zeon Corporation reaches agreement for Aurora Microplates acquisition

Zeon Corporation, a world leader in specialty elastomers, polymers, and specialty chemicals, has reached agreement to acquire Aurora Microplates, ...

February 04, 2022 | News

2022 Japan Prize Laureates Announced

In the field of Materials and ProductionProf. Katalin Kariko https://kyodonewsprwire.jp/img/202201075829-O3-9jI7uI4qProf. Drew Weissman ...

January 26, 2022 | News

Eppendorf expands its portfolio to address customers’ separation needs

The introduction of the portfolio under the Eppendorf umbrella began with the launch of the CP22N and CP30NX high-speed, floor-standing centrifuges in 2021...

January 26, 2022 | News

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...

January 25, 2022 | News

Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer

Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...

January 24, 2022 | News

Kontrol Technologies Expands BioCloud Technology into Japan

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart buildings and cit...

January 17, 2022 | News

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health...

January 11, 2022 | News

PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery platform, today announced it has en...

January 05, 2022 | News

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...

December 29, 2021 | News

Linepharma International Files for Manufacturing, Marketing Approval of the Abortion Pill in Japan

The medication is recognized as the international gold standard for first trimester medical abortioni and is on the World Health Organization (WH...

December 23, 2021 | News

Stay Connected